PL1625150T3 - Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry - Google Patents

Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry

Info

Publication number
PL1625150T3
PL1625150T3 PL04731572T PL04731572T PL1625150T3 PL 1625150 T3 PL1625150 T3 PL 1625150T3 PL 04731572 T PL04731572 T PL 04731572T PL 04731572 T PL04731572 T PL 04731572T PL 1625150 T3 PL1625150 T3 PL 1625150T3
Authority
PL
Poland
Prior art keywords
optionally substituted
alkyl
tripeptides
derivatives
order
Prior art date
Application number
PL04731572T
Other languages
English (en)
Inventor
Hugo Ziegler
Marc Heidl
Dominik Imfeld
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL1625150T3 publication Critical patent/PL1625150T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
PL04731572T 2003-05-08 2004-05-07 Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry PL1625150T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH8072003 2003-05-08
EP04731572A EP1625150B9 (de) 2003-05-08 2004-05-07 Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur
PCT/CH2004/000278 WO2004099237A1 (de) 2003-05-08 2004-05-07 Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur

Publications (1)

Publication Number Publication Date
PL1625150T3 true PL1625150T3 (pl) 2007-05-31

Family

ID=33426270

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04731572T PL1625150T3 (pl) 2003-05-08 2004-05-07 Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry

Country Status (12)

Country Link
US (2) US7863417B2 (pl)
EP (1) EP1625150B9 (pl)
JP (2) JP4769709B2 (pl)
KR (1) KR101116528B1 (pl)
AT (1) ATE350389T1 (pl)
BR (1) BRPI0410074B1 (pl)
CA (1) CA2525476C (pl)
DE (1) DE502004002556D1 (pl)
ES (1) ES2280962T3 (pl)
PL (1) PL1625150T3 (pl)
RU (1) RU2346949C2 (pl)
WO (1) WO2004099237A1 (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1625150T3 (pl) * 2003-05-08 2007-05-31 Dsm Ip Assets Bv Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry
FR2870243B1 (fr) * 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
FR2870244B1 (fr) 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
AU2014271339B2 (en) * 2005-04-27 2016-11-03 The Procter & Gamble Company Personal care compositions
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
WO2007093839A1 (en) * 2006-02-16 2007-08-23 Sederma New polypeptides kxk and their use
ES2283212B1 (es) * 2006-03-31 2008-08-16 Lipotec S.A. Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
KR101332578B1 (ko) 2006-04-28 2013-11-25 디에스엠 아이피 어셋츠 비.브이. 기저막의 단백질 합성 자극용 화장료 조성물
US8586541B2 (en) * 2006-06-01 2013-11-19 Therapeutic Peptides, Inc. Polymeric biosurfactants
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.
EP1992332A1 (en) * 2007-05-08 2008-11-19 Tupperware Products S.A. Cosmetic anti ageing skin care compositions
CH696838A5 (it) * 2007-05-29 2007-12-31 Labo Cosprophar Ag Composizione cosmetica ad effetto lifting per sostenere tessuti cutanei rilassati.
KR101557814B1 (ko) * 2007-07-05 2015-10-06 닛산 가가쿠 고교 가부시키 가이샤 신규 지질트리펩티드성 히드로겔화제 및 히드로겔
CN107028792A (zh) * 2008-05-29 2017-08-11 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
WO2010082177A2 (en) 2009-01-16 2010-07-22 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
CN102325543A (zh) * 2009-02-20 2012-01-18 帝斯曼知识产权资产管理有限公司 用于治疗红斑痤疮及其症状的包含n2-(1-氧代十六烷基)-赖氨酰-缬氨酰-赖氨酸的组合物
EP2408420A1 (en) * 2009-03-16 2012-01-25 DSM IP Assets B.V. Use of tripeptides
US8541361B2 (en) * 2009-04-22 2013-09-24 Dsm Ip Assets B.V. Composition
CN105664223B (zh) * 2009-10-26 2018-12-04 日产化学工业株式会社 化妆料、皮肤外用剂、以及医疗用仪器
US9566218B2 (en) * 2011-03-31 2017-02-14 Nissan Chemical Industries, Ltd. Production method of cosmetic, preparation method of gel for cosmetics, and method of reducing use amount of polymer thickener blended in cosmetic raw materials
RU2613121C2 (ru) 2011-05-10 2017-03-15 Мэри Кэй Инк. Косметические композиции
KR101167285B1 (ko) * 2011-11-18 2012-07-23 에이앤펩주식회사 피부 미백 활성을 갖는 나이아신-펩타이드 및 그의 용도
EP2793828B1 (en) * 2011-12-20 2016-08-24 Unilever PLC Moisturizing composition comprising an aminopeptide mixture
DE102012210379A1 (de) * 2012-06-20 2013-12-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US20140135269A1 (en) * 2012-10-01 2014-05-15 Peter Thomas Roth Labs, Llc Peptide And Protein-Based Formula For Improving The Appearance Of Skin
JP6115086B2 (ja) * 2012-11-13 2017-04-19 味の素株式会社 アミノ酸化合物の酢酸塩を含有する化粧料組成物
WO2014140890A2 (en) 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
WO2015023926A1 (en) 2013-08-15 2015-02-19 Mary Kay Inc. Topical skin compositions for treating wrinkles
GB2549431A (en) 2014-12-29 2017-10-18 Kimberly Clark Co Multifunctional base emulsion
MX362727B (es) 2014-12-29 2019-02-05 Kimberly Clark Co Emulsiones cosméticas.
WO2016121822A1 (ja) * 2015-01-28 2016-08-04 国立大学法人九州大学 脂質ペプチド型化合物を含有する保湿基材
KR20170134653A (ko) * 2015-04-08 2017-12-06 디에스엠 아이피 어셋츠 비.브이. 배합물
CN107708660A (zh) * 2015-06-24 2018-02-16 日产化学工业株式会社 包含脂质肽型化合物的棒状基材
JP6996042B2 (ja) * 2016-09-15 2022-01-17 ディーエスエム アイピー アセッツ ビー.ブイ. 新規化合物
US12410143B2 (en) 2017-01-17 2025-09-09 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase
WO2019060357A1 (en) * 2017-09-21 2019-03-28 Muhammed Majeed PROCESS FOR THE PREPARATION OF TRIPEPTIDE CONTAINING OLEANOLIC ACID AND ASSOCIATED THERAPEUTIC APPLICATIONS
CN108047305B (zh) * 2017-12-08 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的合成方法
CN107987123B (zh) * 2017-12-11 2021-01-01 陕西慧康生物科技有限责任公司 一种十四烷基氨基丁酰缬氨酰胺基丁酸脲三氟乙酸盐的液相合成方法
CN110423264B (zh) * 2019-08-26 2020-12-01 中国科学院长春应用化学研究所 一种基于活化酯高效制备棕榈酰三肽-5的方法
US20210106506A1 (en) * 2019-10-11 2021-04-15 Elc Management Llc Methods for cosmetic skin remodeling
MX2023007788A (es) 2021-01-24 2023-11-17 Michael David Forrest Inhibidores de la atp sintasa, usos cosmeticos y terapeuticos.
US12208150B2 (en) 2021-05-20 2025-01-28 Shielded, Beauty, LLC Antimicrobial skincare composition
IT202200016632A1 (it) * 2022-08-04 2024-02-04 Unifarco S P A Composizioni cosmetiche comprendenti un mix sinergico di attivi con efficacia antietà
AU2023400948A1 (en) * 2022-12-02 2025-06-19 Dsm Ip Assets B.V. Mandelic acid salt of palmitoyl lysylvalyl-lysine
WO2025252826A1 (en) 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Composition comprising an acid addition salt of tetradecylaminocarbonyl-dab-val-dab-oh
WO2025252801A1 (en) * 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Novel peptide compositions
WO2025252800A1 (en) * 2024-06-04 2025-12-11 Dsm Ip Assets B.V. Novel peptide compositions
CN118894902B (zh) * 2024-10-08 2024-12-24 云南苏理生物医药科技有限公司 肽衍生物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336477B1 (pl) * 1971-06-07 1978-10-03
DE2641500A1 (de) 1976-09-15 1978-03-16 Siemens Ag Halbleiteranordnung
US4389342A (en) * 1980-04-02 1983-06-21 Perignon Investments, Ltd. Synthetic hormone-like peptides and method for their synthesis
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
AU633005B2 (en) 1988-06-16 1993-01-21 Procyte Corporation Cosmetic and skin treatment compositions
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
US5593849A (en) * 1993-06-14 1997-01-14 Roy; Benjamin F. Method for detecting antibody against Staphylococcus aureus for replication protein B sequence 275-290 and Arg-Lys-Leu in human body fluids
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
FR2740453B1 (fr) * 1995-10-27 1998-01-16 Bieurope Melanges peptidiques, leur preparation et compositions cosmetiques les contenant
CA2242911A1 (en) * 1996-01-16 1997-07-24 Kay C. Dee Peptides for altering osteoblast adhesion
WO1997037228A1 (en) * 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
US6333167B1 (en) * 2000-03-10 2001-12-25 American Home Products Corp. Methods and reagents for identifying inhibitors of proteolysis of membrane-associated proteins
FR2810323B1 (fr) 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
AU2001297591A1 (en) 2000-11-01 2002-09-19 Zengen, Inc. A sunburn treatment and sunburn prevention method
PL1625150T3 (pl) * 2003-05-08 2007-05-31 Dsm Ip Assets Bv Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry

Also Published As

Publication number Publication date
KR101116528B1 (ko) 2012-02-28
ES2280962T3 (es) 2007-09-16
US20070099842A1 (en) 2007-05-03
JP2007523841A (ja) 2007-08-23
US20110142895A1 (en) 2011-06-16
BRPI0410074B1 (pt) 2020-03-10
US8420778B2 (en) 2013-04-16
CA2525476A1 (en) 2004-11-18
WO2004099237A1 (de) 2004-11-18
EP1625150B1 (de) 2007-01-03
EP1625150A1 (de) 2006-02-15
US7863417B2 (en) 2011-01-04
RU2346949C2 (ru) 2009-02-20
EP1625150B9 (de) 2007-06-13
JP2011137021A (ja) 2011-07-14
JP4769709B2 (ja) 2011-09-07
KR20060009007A (ko) 2006-01-27
BRPI0410074A (pt) 2006-05-23
ATE350389T1 (de) 2007-01-15
CA2525476C (en) 2013-07-30
DE502004002556D1 (de) 2007-02-15
RU2005134130A (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
PL1625150T3 (pl) Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry
MXPA03007249A (es) Compuestos triazolo como inhibidores de mmp.
ATE296797T1 (de) N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
DE60301345D1 (de) Stabilisierte askorbinsäurederivate
MXPA02001314A (es) Derivado de carbamato y fungicida agricola/horticola.
EP1634874A4 (en) imidazolidine
MXPA04006709A (es) Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
EP1548008A4 (en) COMPOUND WITH TGF-BETA-HEMMENDER EFFECT AND THIS MEDICAL COMPOSITION CONTAINING
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
AU2002333155A1 (en) Dermopharmaceutically and cosmetically active oligopeptides
MX2010013275A (es) Compuesto novedoso de uracilo o su sal que tiene actividad inhibidora de desoxiuridin trifosfatasa de humano.
TW200744659A (en) Preparation for preventing and ameliorating wrinkle
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
EP0775487A4 (en) TRIAZINE DERIVATIVE AND MEDICINE
WO2005074897A3 (de) Formulierungshilfsmittel (aminopropansäure derivative) in kosmetischen oder dermatologischen zubereitungen
MXPA05011269A (es) Derivados de acido ascorbico estabilizados.
WO2003016326A1 (fr) Glycolipide et agent therapeutique pour maladies auto-immunes le contenant en tant qu'ingredient actif
EP1342720A3 (en) Epoxysuccinamide derivatives
ATE199317T1 (de) 4-substituierte imidazole enthaltende pharmazeutische zusammensetzungen zur transdermalen verabreichung
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
ATE365722T1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s- triazin, dieser enthaltenden sonnenschutzzusammensetzungen und dessen verwendungen
ATE339431T1 (de) Lipid a und lipid a enthaltende topische, insbesondere kosmetische, zusammensetzung
ATE482199T1 (de) Menthancarbonsäureamidderivate mit kühlenden eigenschaften